Inogen, Inc. (INGN)

Market Cap	191.82M +1.1%
Revenue (ttm)	351.50M +3.4%
Net Income	-24.90M
EPS	-0.92
Shares Out	27.32M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	819,869
Open	7.17
Previous Close	7.19
Day's Range	6.60 - 7.43
52-Week Range	5.34 - 9.13
Beta	1.65
Analysts	Strong Buy
Price Target	12.67 (+80.48%)
Earnings Date	May 7, 2026

About INGN

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airw...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 14, 2014
• Employees: 753
• Stock Exchange: NASDAQ
• Ticker Symbol: INGN
• Website: https://www.provider.inogen.com

Financial Performance

In 2025, Inogen's revenue was $348.67 million, an increase of 3.86% compared to the previous year's $335.71 million. Losses were -$22.75 million, -36.62% less than in 2024.

Analyst Summary

According to 3 analysts, the average rating for INGN stock is "Strong Buy." The 12-month stock price target is $12.67, which is an increase of 80.48% from the latest price.

Price Target

$12.67

(80.48% upside)

Analyst Consensus: Strong Buy